Differential Effect of Methotrexate on the Increased CCR2 Density on Circulating CD4 T Lymphocytes and Monocytes in Active Chronic Rheumatoid Arthritis, with a Down Regulation Only on Monocytes in Responders

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2006 Aug 15

PMID 16905577

Citations 7

Authors

T Ellingsen

N Hornung

B K Moller

J H Poulsen

K Stengaard-Pedersen

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the effect of orally administered methotrexate (MTX) on the density of CC chemokine receptor 2 (CCR2) and CXC chemokine receptor 3 (CXCR3) on circulating monocytes, and the coexpression of CXCR3 and CCR2 on CD4 T lymphocytes in patients with active chronic rheumatoid arthritis.

Methods: All 34 patients with rheumatoid arthritis fulfilled the 1987 American Rheumatism Association criteria and were followed for 16 weeks after starting MTX. Peripheral blood mononuclear cells were analysed for CCR2 and CXCR3 density by three-colour flow cytometry before initiation of MTX and at week 12.

Results: 22 (65%) patients were non-responders, 12 (35%) patients responded to MTX by American College of Rheumatology (ACR)20% criteria, and 8 (24%) of these patients responded by ACR50%. In patients with active rheumatoid arthritis before starting MTX, CCR2 density on circulating monocytes, CD4(+) CXCR3(+) and CD4(+) CXCR3(-) T lymphocytes was increased compared with controls. During 12 weeks of MTX treatment, the CCR2 density on monocytes decreased significantly in the ACR50% group but not in the ACR20% and non-responder groups. The increased CCR2 density on CD4(+) CXCR3(+) and CD4(+) CXCR3(-) T lymphocytes was unaffected by the reduction in disease activity measured in relation to MTX treatment. The percentage of both monocytes and CD4(+) CXCR3(+) and CD4+ CXCR3(-) T lymphocytes among the peripheral circulating mononuclear cells did not change during MTX treatment.

Conclusions: Active chronic rheumatoid arthritis is characterised by enhanced CCR2 density on circulating monocytes and CD4(+) CXCR3(+) and CD4(+) CXCR3(-) T lymphocytes. During MTX treatment, a decrease in CCR2 density on monocytes in the ACR50% responder group was associated with decreased disease activity. The increased CCR2 density on CD4(+) CXCR3(+) and CD4(+) CXCR3(-) T lymphocytes was uninfluenced by MTX and disease activity.

Citing Articles

Effect of DMARDs on the immunogenicity of vaccines.

van Sleen Y, van der Geest K, Huckriede A, van Baarle D, Brouwer E Nat Rev Rheumatol. 2023; 19(9):560-575.

PMID: 37438402 DOI: 10.1038/s41584-023-00992-8.

Chemokine Regulation in Temporomandibular Joint Disease: A Comprehensive Review.

Qiao Y, Li J, Yuh C, Ko F, Mercuri L, Alkhudari J Genes (Basel). 2023; 14(2).

PMID: 36833336 PMC: 9956915. DOI: 10.3390/genes14020408.

The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients.

Aslani M, Ahmadzadeh A, Rezaieyazdi Z, Mortazavi-Jahromi S, Barati A, Hosseini M Recent Pat Inflamm Allergy Drug Discov. 2019; 14(1):69-77.

PMID: 31729947 PMC: 7509734. DOI: 10.2174/1872213X13666191114111822.

Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures.

Kremer J, Lawrence D, Hamilton R, McInnes I RMD Open. 2016; 2(1):e000287.

PMID: 27335660 PMC: 4913203. DOI: 10.1136/rmdopen-2016-000287.

Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naïve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment.

Laurberg T, Ellingsen T, Thorsen J, Moller B, Hansen I, Tarp U Rheumatol Int. 2011; 32(2):501-4.

PMID: 21246373 DOI: 10.1007/s00296-010-1683-z.

References

Katschke Jr K, Rottman J, Ruth J, Qin S, Wu L, Larosa G . Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001; 44(5):1022-32. DOI: 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N. View

Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R . Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136(7):2348-57. View

Haringman J, Gerlag D, Smeets T, Baeten D, Van den Bosch F, Bresnihan B . A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis Rheum. 2006; 54(8):2387-92. DOI: 10.1002/art.21975. View

Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M . Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol. 2001; 126(3):551-9. PMC: 1906244. DOI: 10.1046/j.1365-2249.2001.01679.x. View

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

Akahoshi T, Wada C, Endo H, Hirota K, Hosaka S, Takagishi K . Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor. Arthritis Rheum. 1993; 36(6):762-71. DOI: 10.1002/art.1780360605. View

Siveke J, Hamann A . T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol. 1998; 160(2):550-4. View

Alarcon G, Schrohenloher R, Bartolucci A, WARD J, Williams H, Koopman W . Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression. Arthritis Rheum. 1990; 33(8):1156-61. DOI: 10.1002/art.1780330816. View

Wolfe F, Kleinheksel S, Cathey M, Hawley D, Spitz P, Fries J . The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol. 1988; 15(10):1480-8. View

10.

Goede V, Brogelli L, Ziche M, Augustin H . Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer. 1999; 82(5):765-70. DOI: 10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f. View

11.

Volin M, Campbell P, Connors M, Woodruff D, Koch A . The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production. Exp Mol Pathol. 2002; 73(2):84-92. DOI: 10.1006/exmp.2002.2460. View

12.

Bonecchi R, Bianchi G, Bordignon P, DAmbrosio D, Lang R, Borsatti A . Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998; 187(1):129-34. PMC: 2199181. DOI: 10.1084/jem.187.1.129. View

13.

Haringman J, Smeets T, Reinders-Blankert P, Tak P . Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis. 2005; 65(3):294-300. PMC: 1798063. DOI: 10.1136/ard.2005.037176. View

14.

Felson D, Anderson J, Boers M, Bombardier C, Furst D, Goldsmith C . American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995; 38(6):727-35. DOI: 10.1002/art.1780380602. View

15.

Kuziel W, Morgan S, Dawson T, Griffin S, SMITHIES O, Ley K . Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A. 1997; 94(22):12053-8. PMC: 23699. DOI: 10.1073/pnas.94.22.12053. View

16.

Segal R, Caspi D, Tishler M, Wigler I, Yaron M . Short term effects of low dose methotrexate on the acute phase reaction in patients with rheumatoid arthritis. J Rheumatol. 1989; 16(7):914-7. View

17.

Salcedo R, Ponce M, Young H, Wasserman K, Ward J, Kleinman H . Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood. 2000; 96(1):34-40. View

18.

Nanki T, Lipsky P . Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int Immunol. 2000; 12(12):1659-67. DOI: 10.1093/intimm/12.12.1659. View

19.

Warmington K, Boring L, Ruth J, Sonstein J, Hogaboam C, Curtis J . Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am J Pathol. 1999; 154(5):1407-16. PMC: 1866581. DOI: 10.1016/S0002-9440(10)65394-1. View

20.

Gong J, Ratkay L, Waterfield J, Clark-Lewis I . An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med. 1997; 186(1):131-7. PMC: 2198969. DOI: 10.1084/jem.186.1.131. View